{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:33:33Z","timestamp":1790721213884,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12869-4","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:02:37Z","timestamp":1725426157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019"],"prefix":"10.1186","volume":"24","author":[{"given":"Omar","family":"Al Ta\u2019ani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Al-Ajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Jagdish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himsikhar","family":"Khataniar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam","family":"Aleyadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Al-Bitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tavankit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"10","key":"12869_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"12869_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337.","journal-title":"J Hepatol"},{"issue":"6","key":"12869_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264\u2013e1.","journal-title":"Gastroenterology"},{"issue":"9","key":"12869_CR4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/MEG.0000000000001837","volume":"33","author":"X Guan","year":"2021","unstructured":"Guan X, Xing F, Li Y. Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis. Eur J Gastroenterol Hepatol. 2021;33(9):1218\u201321.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"12869_CR5","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/ijc.25797","volume":"128","author":"J Ertle","year":"2011","unstructured":"Ertle J, Dech\u00eane A, Sowa JP, Penndorf V, Herzer K, Kaiser G, et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011;128(10):2436\u201343.","journal-title":"Int J Cancer"},{"issue":"9","key":"12869_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/liv.12818","volume":"35","author":"JW Park","year":"2015","unstructured":"Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155\u201366.","journal-title":"Liver Int"},{"issue":"2","key":"12869_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s44197-023-00109-0","volume":"13","author":"G Cao","year":"2023","unstructured":"Cao G, Liu J, Liu M. Global, regional, and national trends in incidence and mortality of primary liver cancer and its underlying etiologies from 1990 to 2019: results from the global burden of Disease Study 2019. J Epidemiol Glob Health. 2023;13(2):344\u201360.","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"12869_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1055-9965.EPI-19-1052","volume":"29","author":"X Zhang","year":"2020","unstructured":"Zhang X, El-Serag HB, Thrift AP. Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(1):88\u201394.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"12869_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.29498","volume":"67","author":"PC Valery","year":"2018","unstructured":"Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology. 2018;67(2):600\u201311.","journal-title":"Hepatology"},{"issue":"4","key":"12869_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","volume":"152","author":"DL White","year":"2017","unstructured":"White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812\u201320.","journal-title":"Gastroenterology"},{"issue":"8","key":"12869_CR11","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ajg.2013.160","volume":"108","author":"TM Welzel","year":"2013","unstructured":"Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108(8):1314.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"12869_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485\u201391.","journal-title":"J Clin Oncol"},{"issue":"3","key":"12869_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/hep.32355","volume":"76","author":"J Han","year":"2022","unstructured":"Han J, Wang B, Liu W, et al. Declining disease burden of HCC in the United States, 1992\u20132017: a population-based analysis. Hepatology. 2022;76(3):576\u201388.","journal-title":"Hepatology"},{"issue":"13","key":"12869_CR14","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1002\/cncr.32794","volume":"126","author":"JL Petrick","year":"2020","unstructured":"Petrick JL, Florio AA, Loomba R, McGlynn KA. Have incidence rates of liver cancer peaked in the United States? Cancer. 2020;126(13):3151\u201355.","journal-title":"Cancer"},{"issue":"10258","key":"12869_CR15","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"H Wang","year":"2020","unstructured":"Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abolhassani H, Abreu LG, Abrigo MR, Abushouk AI. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1160\u2013203.","journal-title":"Lancet"},{"key":"12869_CR16","unstructured":"Global Health Data Exchange. GHDx Query Tool. Institute for Health Metrics and Evaluation (IHME). http:\/\/ghdx.healthdata.org\/gbd-results-tool. Accessed [01\/15\/2024]."},{"key":"12869_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2024; Version 4.3.3. https:\/\/www.R-project.org\/. Accessed [01\/15\/2024]."},{"issue":"5","key":"12869_CR18","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","volume":"60","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60(5):1767\u201375.","journal-title":"Hepatology"},{"issue":"1","key":"12869_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"12869_CR20","unstructured":"National Cancer Institute. SEER Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer. Retrieved from https:\/\/seer.cancer.gov\/statfacts\/html\/livibd.html"},{"key":"12869_CR21","unstructured":"Centers for Disease Control and Prevention (CDC). Hepatitis C Surveillance in the United States for 2019. 2024. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/HepC.htm. Accessed 15 Jan 2024."},{"key":"12869_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108:175\u201381.","journal-title":"Am J Public Health"},{"issue":"10","key":"12869_CR23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/cid\/ciu643","volume":"59","author":"AG Suryaprasad","year":"2014","unstructured":"Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012. Clin Infect Dis. 2014;59(10):1411\u20139.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"12869_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308\u201319.","journal-title":"Genes Dis"},{"issue":"3","key":"12869_CR25","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729240","volume":"24","author":"A Shiani","year":"2017","unstructured":"Shiani A, Narayanan S, Pena L, Friedman M. The role of diagnosis and treatment of underlying liver disease for the prognosis of primary liver cancer. Cancer Control. 2017;24(3):1073274817729240.","journal-title":"Cancer Control"},{"issue":"8","key":"12869_CR26","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","volume":"25","author":"F Turati","year":"2014","unstructured":"Turati F, Galeone C, Rota M, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2014;25(8):1526\u201335.","journal-title":"Ann Oncol"},{"issue":"8","key":"12869_CR27","doi-asserted-by":"publisher","first-page":"e2328328","DOI":"10.1001\/jamanetworkopen.2023.28328","volume":"6","author":"M Shi","year":"2023","unstructured":"Shi M, Luo C, Oduyale OK, Zong X, LoConte NK, Cao Y. Alcohol consumption among adults with a cancer diagnosis in the all of Us Research Program. JAMA Netw Open. 2023;6(8):e2328328.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"12869_CR28","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"4","key":"12869_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3322\/caac.21402","volume":"67","author":"F Islami","year":"2017","unstructured":"Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer occurrence in the United States by race\/ethnicity and state. CA Cancer J Clin. 2017;67(4):273\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"12869_CR30","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/cid\/ciz669","volume":"70","author":"JZ Shing","year":"2020","unstructured":"Shing JZ, Ly KN, Xing J, Teshale EH, Jiles RB. Prevalence of hepatitis B virus infection among US adults aged 20\u201359 years with a history of injection drug use: National Health and Nutrition Examination Survey, 2001\u20132016. Clin Infect Dis. 2020;70(12):2619\u201327.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12869_CR31","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264\u2013e12731.","journal-title":"Gastroenterology"},{"issue":"10","key":"12869_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/cid\/ciw111","volume":"62","author":"KN Ly","year":"2016","unstructured":"Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising mortality associated with hepatitis C virus in the United States, 2003\u20132013. Clin Infect Dis. 2016;62(10):1287\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"12869_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C. Guidance Panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686\u2013721.","journal-title":"Hepatology"},{"issue":"1","key":"12869_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"12869_CR35","first-page":"293","volume":"69","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2018;69(1):293\u2013304.","journal-title":"Hepatology"},{"key":"12869_CR36","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief. 2020;(360):1\u20138."},{"issue":"9","key":"12869_CR37","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10552-018-1059-3","volume":"29","author":"S Melkonian","year":"2018","unstructured":"Melkonian S, Jim M, Reilley B, Erdrich J, Berkowitz Z, Wiggins C, et al. Incidence of primary liver cancer in American indians and Alaska Natives. Cancer Causes Control. 2018;29(9):1999\u20132009.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"12869_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/CEJ.0000000000000712","volume":"31","author":"C Santucci","year":"2021","unstructured":"Santucci C, Medina H, Carioli G, Negri E, Vecchia C, Pinheiro P. Cancer mortality in Italian populations: differences between Italy and the USA. Eur J Cancer Prev. 2021;31(4):393\u201399.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"12869_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2468-1253(16)30161-3","volume":"2","author":"JD Yang","year":"2014","unstructured":"Yang JD, Mohamed EA, Aziz AOA, Shousha HI, Hashem MB, Nabeel MM, Roberts LR. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. Lancet Gastroenterol Hepatol. 2014;2(2):103\u201311.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5834","key":"12869_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u20134.","journal-title":"Science"},{"key":"12869_CR41","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 1","key":"12869_CR42","first-page":"S2","volume":"13","author":"JG Chen","year":"2006","unstructured":"Chen JG, Parkin DM, Chen QG, Lu JH, Shen QJ, Zhang BC, Zhu YR. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2006;13(Suppl 1):S2\u20133.","journal-title":"J Med Screen"},{"issue":"4","key":"12869_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1053\/j.gastro.2018.07.008","volume":"155","author":"D Kim","year":"2018","unstructured":"Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G. Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016. Gastroenterology. 2018;155(4):1154\u2013e11633.","journal-title":"Gastroenterology"},{"issue":"7","key":"12869_CR44","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/ijc.30211","volume":"139","author":"JL Petrick","year":"2016","unstructured":"Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA. International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007. Int J Cancer. 2016;139(7):1534\u201345.","journal-title":"Int J Cancer"},{"issue":"12","key":"12869_CR45","doi-asserted-by":"publisher","first-page":"e27717","DOI":"10.1371\/journal.pone.0027717","volume":"6","author":"T Mitchell","year":"2011","unstructured":"Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B\u2014United States, 1974\u20132008. PLoS ONE. 2011;6(12):e27717.","journal-title":"PLoS ONE"},{"issue":"2","key":"12869_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, Holtzman D. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381.","journal-title":"Am J Public Health"},{"issue":"6","key":"12869_CR47","first-page":"431","volume":"53","author":"J Ha","year":"2019","unstructured":"Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Ahmed A. Race\/Ethnicity-specific disparities in hepatocellular carcinoma stage at diagnosis and its impact on receipt of curative therapies. J Clin Gastroenterol. 2019;53(6):431\u20139.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"12869_CR48","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/cncr.24817","volume":"116","author":"A Artinyan","year":"2010","unstructured":"Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Moridzadeh R, Lai LL, Asch SM. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer. 2010;116(5):1367\u201377.","journal-title":"Cancer"},{"issue":"2","key":"12869_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367\u2013e3755.","journal-title":"Gastroenterology"},{"issue":"4","key":"12869_CR50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829\u201346.","journal-title":"J Hepatol"},{"issue":"18","key":"12869_CR51","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675\u201385.","journal-title":"N Engl J Med"},{"issue":"6","key":"12869_CR52","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005\u201323.","journal-title":"Hepatology"},{"issue":"12","key":"12869_CR53","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","volume":"6","author":"RR Mummadi","year":"2008","unstructured":"Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396\u2013402.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"12869_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2014.02.026","volume":"173","author":"CS Kwok","year":"2014","unstructured":"Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20\u20138.","journal-title":"Int J Cardiol"},{"issue":"4","key":"12869_CR55","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/add.12832","volume":"110","author":"TF Babor","year":"2015","unstructured":"Babor TF, Robaina K, Jernigan D. The influence of industry actions on the availability of alcoholic beverages in the African region. Addiction. 2015;110(4):561\u201371.","journal-title":"Addiction"},{"issue":"10","key":"12869_CR56","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/aje\/kwn237","volume":"168","author":"H Hagan","year":"2008","unstructured":"Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol. 2008;168(10):1099\u2013109.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"12869_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235\u201348.","journal-title":"Int J Epidemiol"},{"key":"12869_CR58","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"issue":"9","key":"12869_CR59","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/bjc.2011.360","volume":"105","author":"WP Koh","year":"2011","unstructured":"Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, Yu MC. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer. 2011;105(9):1430\u20135.","journal-title":"Br J Cancer"},{"key":"12869_CR60","unstructured":"CDC. Testing recommendations for hepatitis C virus infection. [Accessed 01\/15\/2024]. https:\/\/www.cdc.gov\/hepatitis\/statistics\/index.htm"},{"issue":"2","key":"12869_CR61","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Morgan TR, Hepatitis AASLD-IDSA. Guidance Panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686\u2013721.","journal-title":"Hepatology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T06:07:40Z","timestamp":1725430060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12869"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12869-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given that we utilized publicly accessible data, no IRB or individual consent was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Given that we utilized publicly accessible data, individual consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1098"}}